Hazel Hunt insider trades

Open-market stock purchases and sales by Hazel Hunt, Chief Scientific Officer at Corcept Therapeutics Inc, from SEC Form 4 filings since Jul 13, 2020.

Recent trades

DateStockTradeValue
Feb 27, 2026CORT Corcept Therapeutics IncBought (not open market)—
Feb 9, 2026CORT Corcept Therapeutics IncSold (not open market)$3.2M
Feb 9, 2026CORT Corcept Therapeutics IncBought (not open market)—

Companies traded

  • CORT Corcept Therapeutics Inc: 1 sale, last Feb 27, 2026

Get free alerts when Hazel Hunt files a new trade →